Second Sight CEO Greenberg: Next-gen 'bionic eye' could treat nearly all forms of blindness

Second Sight Medical, which yesterday saw its initial public offering close up nearly 122%, could have its next-generation 'bionic eye' device ready for nearly all blind patients 'within a couple of years,' CEO Dr. Robert Greenberg tells MassDevice.com.

Second Sight Medical Products Inc.

News Well, Initial Public Offering (IPO), Optical/Ophthalmic, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1x5fRe3